- 同花顺特色产品
- 〈高级诊股〉全方位深度分析，提供明确投资建议
- 〈舆情监控〉实时监控个股情报
- 短期趋势：
股价的强势特征已经确立，短线可能回调。
- 中期趋势：
有加速上涨趋势。
- 长期趋势：
迄今为止，共6家主力机构，持仓量总计4.15亿股，占流通A股22.93%
- 波段诊断：
-
技术面诊股
诊断结果：7.3技术面打败了53%的股票
技术面评分前10的股票
近期的平均成本为6.10元，股价在成本上方运行。多头行情中，并且有加速上涨趋势。
平均成本
近期的平均成本为6.10元，股价在成本上方运行。
[{"text":"\u5e73\u5747\u6210\u672c","value":"6.10","date":1594611496,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势接近大盘，接近行业平均水平。
[{"date":"2020.07.13","stock":"3.72","trade":"4.28","ind":"3.50"},{"date":"2020.07.10","stock":"-0.50","trade":"0.34","ind":"-0.61"},{"date":"2020.07.09","stock":"3.84","trade":"3.72","ind":"2.60"},{"date":"2020.07.08","stock":"0.70","trade":"0.57","ind":"1.84"},{"date":"2020.07.07","stock":"1.25","trade":"1.22","ind":"1.72"},{"date":"2020.07.06","stock":"4.27","trade":"1.97","ind":"4.09"},{"date":"2020.07.03","stock":"0.75","trade":"0.63","ind":"1.33"},{"date":"2020.07.02","stock":"0.38","trade":"0.68","ind":"1.29"},{"date":"2020.07.01","stock":"-0.93","trade":"-0.85","ind":"1.01"},{"date":"2020.06.30","stock":"0.56","trade":"1.26","ind":"2.04"},{"date":"2020.06.29","stock":"1.71","trade":"0.21","ind":"-0.52"},{"date":"2020.06.24","stock":"-1.13","trade":"-0.91","ind":"0.17"},{"date":"2020.06.23","stock":"1.92","trade":"1.10","ind":"0.78"},{"date":"2020.06.22","stock":"-0.95","trade":"-0.27","ind":"0.29"},{"date":"2020.06.19","stock":"1.74","trade":"0.30","ind":"1.51"},{"date":"2020.06.18","stock":"-0.74","trade":"-2.71","ind":"0.65"},{"date":"2020.06.17","stock":"3.03","trade":"2.23","ind":"0.19"},{"date":"2020.06.16","stock":"0.96","trade":"1.09","ind":"1.85"},{"date":"2020.06.15","stock":"0.19","trade":"1.92","ind":"-0.53"},{"date":"2020.06.12","stock":"-0.57","trade":"1.11","ind":"0.07"},{"date":"2020.06.11","stock":"-5.06","trade":"-0.65","ind":"-0.81"}]
华邦健康,深证成指,化学制药指数
压力支撑
该股压力位为6.00元，支撑位为5.83元。
[{"text":"\u538b\u529b\u4f4d","value":"6.00","date":1594569600,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"5.83","date":1594569600,"color":"0x0b52a1"}]
多空趋势
多头行情中，并且有加速上涨趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.1资金面打败了19%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：07月14日 12:30
| 机构今日流向(万元) | 1319.37 | 机构5日流向(万元) | 1598.38 |
| 机构10日流向(万元) | -3128.70 | 机构20日流向(万元) | -4633.51 |
机构持仓
2020-03-31 与 2019-12-31 相比，主力机构持仓量减少2707.65万股，其中基金数没有增加，主力净减仓77家，请投资者中长期谨慎为宜。
截止2020-03-31，共6家主力机构（基金3家，一般法人3家），持仓量总计41484.6万股，占流通A股22.93%
其中，基金持仓与2019-12-31相比：
增仓：1家 ，增持 25.88万股
减仓：1家 ，减持 131.37万股
新出现在主力名单中：1家 ，持有21.27万股
从主力名单中消失：78家 ，原持有2007.72万股
其中，基金持仓与2019-12-31相比：
增仓：1家 ，增持 25.88万股
减仓：1家 ，减持 131.37万股
新出现在主力名单中：1家 ，持有21.27万股
从主力名单中消失：78家 ，原持有2007.72万股
消息面诊股
诊断结果：5.6消息面打败了15%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华邦健康：7月13日融资净买入840.51万元 环
2020-07-14 - 华邦健康14:30大单揭秘:主动大单卖出11601
2020-07-13 - 机会情报：蝗虫持续入侵态势严重 农药行业迎利好
2020-07-13 - 华邦健康：一期产能是原有产能的4-8倍 能完全解决
2020-07-10 - 华邦健康：公司目前未入股投资基金和战略投资基金
2020-07-10 - 华邦健康：目前公司十余个重要产品的一致性评价申报工
2020-07-10 - 华邦健康：公司优质的旅游资源和经验丰富的管理团队共
2020-07-10 - 华邦健康：自2月份以来 公司旅游资产所在景区根据当
2020-07-10 - 华邦健康10:30大单揭秘:主动大单卖出38375
2020-07-10 - 华邦健康：7月9日融资净买入1172.25万元 环
2020-07-10
消息列表
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-06-30 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-06-06 |
| 一般消息 | 股东大会 | 临时股东大会 | 2020-05-28 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-05-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-04-29 |
| 利好 | 分红转增 | 10派2.20元(含税) | 2020-04-15 |
| 一般消息 | 募资投向 | 2020-04-15 | |
| 一般消息 | 高管变动 | 因个人原因 | 2020-04-09 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2020-03-14 |
| 一般消息 | 重大事项 | 关联交易 | 2019-12-31 |
| 利好 | 重大事项 | 参股拟上市公司或非上市公司金融机构 | 2019-12-31 |
| 一般消息 | 重大事项 | 关联交易 | 2019-12-11 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2019-11-30 |
| 一般消息 | 分红转增 | 不分配不转增 | 2019-08-22 |
| 一般消息 | 重大事项 | 关联交易 | 2019-08-22 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 2条 | 0条 | 2条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：7.4行业面打败了47%的股票
化学制药行业最新资金流向
近10日来该行业走势明显向上，接近大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，接近大盘。
[{"date":"2020.07.13","price":"3.50","value":"4.28"},{"date":"2020.07.10","price":"-0.61","value":"0.34"},{"date":"2020.07.09","price":"2.60","value":"3.72"},{"date":"2020.07.08","price":"1.84","value":"0.57"},{"date":"2020.07.07","price":"1.72","value":"1.22"},{"date":"2020.07.06","price":"4.09","value":"1.97"},{"date":"2020.07.03","price":"1.33","value":"0.63"},{"date":"2020.07.02","price":"1.29","value":"0.68"},{"date":"2020.07.01","price":"1.01","value":"-0.85"},{"date":"2020.06.30","price":"2.04","value":"1.26"},{"date":"2020.06.29","price":"-0.52","value":"0.21"},{"date":"2020.06.24","price":"0.17","value":"-0.91"},{"date":"2020.06.23","price":"0.78","value":"1.10"},{"date":"2020.06.22","price":"0.29","value":"-0.27"},{"date":"2020.06.19","price":"1.51","value":"0.30"},{"date":"2020.06.18","price":"0.65","value":"-2.71"},{"date":"2020.06.17","price":"0.19","value":"2.23"},{"date":"2020.06.16","price":"1.85","value":"1.09"},{"date":"2020.06.15","price":"-0.53","value":"1.92"},{"date":"2020.06.12","price":"0.07","value":"1.11"},{"date":"2020.06.11","price":"-0.81","value":"-0.65"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 信立泰 | 75.74% | 32.11% | 6.7分 |
| 2 | 景峰医药 | 64.13% | 18.20% | 7.1分 |
| 3 | 泽璟制药 | 54.60% | 34.45% | 6.2分 |
| 4 | 誉衡药业 | 44.08% | 24.08% | 6.1分 |
| 5 | 金达威 | 44.00% | 37.06% | 7.1分 |
| 6 | 亿帆医药 | 43.96% | 17.31% | 6.8分 |
| 8 | 微芯生物 | 41.74% | 26.97% | 5.9分 |
| 10 | 华东医药 | 36.21% | 17.71% | 6.9分 |
| 12 | 浙江医药 | 32.15% | 8.42% | 6.1分 |
| 14 | 九典制药 | 31.54% | 15.14% | 5.5分 |
| 16 | 南新制药 | 30.79% | 17.92% | 5.7分 |
| 18 | 京新药业 | 30.29% | 22.29% | 6.0分 |
| 20 | 联环药业 | 30.18% | 13.93% | 6.4分 |
| 22 | 华北制药 | 29.07% | 13.46% | 6.2分 |
| 24 | 药石科技 | 28.36% | 9.63% | 6.5分 |
| 26 | 圣达生物 | 27.25% | 18.50% | 6.0分 |
| 28 | 金城医药 | 25.10% | 8.45% | 6.6分 |
| 30 | 向日葵 | 24.47% | 11.74% | 5.5分 |
| 32 | 北陆药业 | 24.12% | 9.62% | 5.1分 |
| 34 | 新诺威 | 23.05% | 17.00% | 6.3分 |
| 36 | 海思科 | 22.25% | 11.05% | 6.7分 |
| 38 | 康弘药业 | 22.01% | 6.91% | 6.4分 |
| 40 | 同和药业 | 21.08% | 9.69% | 6.5分 |
| 42 | 山河药辅 | 20.78% | 13.47% | 6.1分 |
| 44 | 海普瑞 | 19.59% | 3.95% | 6.5分 |
| 46 | 灵康药业 | 19.10% | 15.84% | 6.6分 |
| 48 | 健康元 | 18.98% | 19.44% | 6.8分 |
| 50 | 天宇股份 | 18.82% | 10.96% | 6.5分 |
| 52 | 奥赛康 | 18.38% | 12.00% | 6.1分 |
| 54 | 振东制药 | 18.20% | 7.66% | 6.3分 |
| 56 | 现代制药 | 18.03% | 5.26% | 6.4分 |
| 58 | 华仁药业 | 17.31% | 8.10% | 6.1分 |
| 60 | 亚太药业 | 16.99% | 9.46% | 5.8分 |
| 62 | 江苏吴中 | 16.75% | 6.55% | 5.7分 |
| 64 | 吉贝尔 | 16.48% | 10.17% | 5.4分 |
| 66 | 新和成 | 16.12% | 6.23% | 6.1分 |
| 68 | 罗欣药业 | 15.81% | 6.85% | 5.7分 |
| 70 | 千红制药 | 15.40% | 5.64% | 5.2分 |
| 72 | 东阳光 | 15.10% | 4.33% | 6.6分 |
| 74 | 仟源医药 | 13.96% | 6.22% | 5.8分 |
| 76 | 卫信康 | 13.20% | 5.95% | 5.2分 |
| 78 | 金石亚药 | 13.07% | 4.47% | 5.1分 |
| 80 | 威尔药业 | 12.13% | 3.40% | 6.0分 |
| 82 | 金陵药业 | 12.04% | 3.57% | 5.7分 |
| 84 | 海辰药业 | 11.98% | 4.79% | 5.4分 |
| 86 | 尔康制药 | 11.55% | 7.33% | 5.3分 |
| 88 | 哈三联 | 11.34% | 2.94% | 5.0分 |
| 90 | 通化金马 | 10.77% | 5.31% | 5.5分 |
| 92 | 广济药业 | 9.89% | 3.67% | 5.1分 |
| 94 | 北大医药 | 8.91% | 5.42% | 5.6分 |
| 96 | 恩华药业 | 8.27% | 8.73% | 6.1分 |
| 98 | 东诚药业 | 7.28% | 10.51% | 6.8分 |
| 100 | 莱美药业 | 6.08% | 10.13% | 6.0分 |
| 102 | 圣济堂 | 4.56% | 4.93% | 5.7分 |
| 104 | ST冠福 | 2.06% | 0.00% | 5.8分 |
| 106 | 司太立 | 1.45% | 5.09% | 6.0分 |
| 108 | 仙琚制药 | 0.23% | 8.69% | 6.7分 |
| 110 | *ST辅仁 | -4.40% | 0.77% | 4.8分 |
| 112 | 济民制药 | -33.96% | 2.26% | 4.9分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2020-03-31 ]公司经营
盈利能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 73/206 ， 88/206。
[{"date":"2020-03-31","value":"0.88","vol":"2.08"},{"date":"2019-12-31","value":"6.74","vol":"1.91"},{"date":"2019-09-30","value":"5.57","vol":"4.68"},{"date":"2019-06-30","value":"3.29","vol":"3.80"},{"date":"2019-03-31","value":"1.10","vol":"1.69"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
0.88 | 6.74 | 5.57 | 3.29 | 1.10 |
| 行业(%) | 2.08 | 1.91 | 4.68 | 3.80 | 1.69 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"37.81","vol":"53.26"},{"date":"2019-12-31","value":"46.53","vol":"54.52"},{"date":"2019-09-30","value":"45.61","vol":"53.43"},{"date":"2019-06-30","value":"43.01","vol":"54.44"},{"date":"2019-03-31","value":"40.97","vol":"53.54"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
37.81 | 46.53 | 45.61 | 43.01 | 40.97 |
| 行业(%) | 53.26 | 54.52 | 53.43 | 54.44 | 53.54 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 50/206 ， 61/206。
[{"date":"2020-03-31","value":"-8.09","vol":"-10.30"},{"date":"2019-12-31","value":"-4.56","vol":"10.54"},{"date":"2019-09-30","value":"-4.58","vol":"11.68"},{"date":"2019-06-30","value":"-1.15","vol":"12.49"},{"date":"2019-03-31","value":"-9.39","vol":"10.10"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-8.09 | -4.56 | -4.58 | -1.15 | -9.39 |
| 行业(%) | -10.30 | 10.54 | 11.68 | 12.49 | 10.10 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"-17.15","vol":"-26.40"},{"date":"2019-12-31","value":"22.46","vol":"-51.08"},{"date":"2019-09-30","value":"3.90","vol":"156.93"},{"date":"2019-06-30","value":"-5.07","vol":"19.36"},{"date":"2019-03-31","value":"3.63","vol":"22.13"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-17.15 | 22.46 | 3.90 | -5.07 | 3.63 |
| 行业(%) | -26.40 | -51.08 | 156.93 | 19.36 | 22.13 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 83/206 ， 47/206。
[{"date":"2020-03-31","value":"0.08","vol":"0.12"},{"date":"2019-12-31","value":"0.38","vol":"0.62"},{"date":"2019-09-30","value":"0.28","vol":"0.45"},{"date":"2019-06-30","value":"0.19","vol":"0.30"},{"date":"2019-03-31","value":"0.09","vol":"0.14"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.08 | 0.38 | 0.28 | 0.19 | 0.09 |
| 行业(次) | 0.12 | 0.62 | 0.45 | 0.30 | 0.14 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.67","vol":"0.65"},{"date":"2019-12-31","value":"2.67","vol":"3.45"},{"date":"2019-09-30","value":"2.03","vol":"2.51"},{"date":"2019-06-30","value":"1.44","vol":"1.63"},{"date":"2019-03-31","value":"0.74","vol":"0.79"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.67 | 2.67 | 2.03 | 1.44 | 0.74 |
| 行业(次) | 0.65 | 3.45 | 2.51 | 1.63 | 0.79 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2020-03-31","value":"7.98","vol":"6.85"},{"date":"2019-12-31","value":"30.69","vol":"19.97"},{"date":"2019-09-30","value":"23.43","vol":"9.27"},{"date":"2019-06-30","value":"22.56","vol":"13.75"},{"date":"2019-03-31","value":"5.15","vol":"6.21"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 7.98 | 30.69 | 23.43 | 22.56 | 5.15 |
| 行业 | 6.85 | 19.97 | 9.27 | 13.75 | 6.21 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"","vol":"0.00"},{"date":"2019-12-31","value":"2.07","vol":"2.67"},{"date":"2019-09-30","value":"","vol":"0.02"},{"date":"2019-06-30","value":"1.72","vol":"2.30"},{"date":"2019-03-31","value":"","vol":"0.27"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 2.07 | - | 1.72 | - |
| 行业 | 0.00 | 2.67 | 0.02 | 2.30 | 0.27 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 75/206 ， 40/206。
[{"date":"2020-03-31","value":"0.96","vol":"2.81"},{"date":"2019-12-31","value":"0.92","vol":"2.53"},{"date":"2019-09-30","value":"1.00","vol":"2.64"},{"date":"2019-06-30","value":"0.96","vol":"2.56"},{"date":"2019-03-31","value":"1.02","vol":"2.66"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.96 | 0.92 | 1.00 | 0.96 | 1.02 |
| 行业 | 2.81 | 2.53 | 2.64 | 2.56 | 2.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"0.69","vol":"2.12"},{"date":"2019-12-31","value":"0.62","vol":"1.88"},{"date":"2019-09-30","value":"0.74","vol":"1.79"},{"date":"2019-06-30","value":"0.73","vol":"1.77"},{"date":"2019-03-31","value":"0.80","vol":"1.72"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.69 | 0.62 | 0.74 | 0.73 | 0.80 |
| 行业 | 2.12 | 1.88 | 1.79 | 1.77 | 1.72 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 10/206 ， 13/206。
[{"date":"2020-03-31","value":"52.34","vol":"35.72"},{"date":"2019-12-31","value":"50.28","vol":"36.61"},{"date":"2019-09-30","value":"51.71","vol":"34.88"},{"date":"2019-06-30","value":"51.96","vol":"35.00"},{"date":"2019-03-31","value":"52.65","vol":"32.87"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
52.34 | 50.28 | 51.71 | 51.96 | 52.65 |
| 行业(%) | 35.72 | 36.61 | 34.88 | 35.00 | 32.87 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2020-03-31","value":"1.56","vol":"0.84"},{"date":"2019-12-31","value":"1.43","vol":"1.51"},{"date":"2019-09-30","value":"1.52","vol":"0.69"},{"date":"2019-06-30","value":"1.53","vol":"1.07"},{"date":"2019-03-31","value":"1.57","vol":"0.69"}]
| 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
1.56 | 1.43 | 1.52 | 1.53 | 1.57 |
| 行业(%) | 0.84 | 1.51 | 0.69 | 1.07 | 0.69 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2020年的收益，请投资者后续关注。
[{"date":"2016","yellowRectValue":"5.67","blueLineValue":"","type":""},{"date":"2017","yellowRectValue":"5.06","blueLineValue":"","type":""},{"date":"2018","yellowRectValue":"5.06","blueLineValue":"","type":""},{"date":"2019","yellowRectValue":"6.20","blueLineValue":"","type":""},{"date":"2020","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]